External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

Autor: Nuhn, P., May, M., Fritsche, H.-M., Buchner, A., Brookman-May, S., Bolenz, C., Moritz, R., Herrmann, E., Burger, M., Höfner, T., Ellinger, J., Tilki, D., Roigas, J., Zacharias, M., Trojan, L., Wülfing, C., May, F., Melchior, S., Haferkamp, A., Gilfrich, C., Hohenfellner, M., Wieland, W.F., Müller, S.C., Stief, C.G., Bastian, P.J.
Zdroj: In European Journal of Surgical Oncology July 2012 38(7):637-642
Databáze: ScienceDirect